Pembrolizumab more value in squamous cell carcinomas or adenocarcinomas ASCO GI 2016
Dr. Toshihiko Doi, MD of National Cancer Center Hospital East, Japan discusses pembrolizumab and more value in squamous cell carcinomas or adenocarcinomas ASCO GI 2016
Author: ASCOGI2016
Added: 01/29/2016
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Carcinoma | Hospitals | Squamous Cell Carcinoma